Bora Pharmaceuticals Co., Ltd. (TPE:6472)
Taiwan · Delayed Price · Currency is TWD 412.50
-3.50 (-0.84%)
Sep 8, 2026, 1:30 PM CST
Bora Pharmaceuticals Market Cap
Bora Pharmaceuticals has a market cap or net worth of 52.95 billion as of September 4, 2026. Its market cap has decreased by -41.72% in one year.
Market Cap
52.95B
Enterprise Value
68.69B
Revenue
19.56B
Ranking
n/a
PE Ratio
44.77
Stock Price
412.50
ChartMarket Cap Chart
Since October 3, 2014, Bora Pharmaceuticals's market cap has increased from 3.16B to 52.95B, an increase of 1,574.69%. That is a compound annual growth rate of 26.62%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2026 | 52.95B | -12.51% |
| Dec 31, 2025 | 60.52B | -22.12% |
| Dec 31, 2024 | 77.71B | 20.27% |
| Dec 29, 2023 | 64.61B | 107.61% |
| Dec 30, 2022 | 31.12B | 150.04% |
| Dec 30, 2021 | 12.45B | 17.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 23, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Lotus Pharmaceutical | 49.08B |
| Center Laboratories | 23.85B |
| TTY Biopharm Company | 19.15B |
| Handa Pharmaceuticals | 17.47B |
| Synmosa Biopharma | 16.08B |
| ScinoPharm Taiwan | 15.10B |
| YungShin Global Holding | 14.94B |
| Grape King Bio | 13.41B |